Community Research and Development Information Service - CORDIS


Today's research for tomorrow's treatments, Cell factory research projects with clinical relevance



Since the market authorisation of the first biotechnologically produced medicine in 1982, biotechnology research is a key element in the development of new diagnostic tools, new therapeutic substances and strategies. The European Commission has supported biotechnology research for more than a decade and this has lead to the establishment of collaborative links among European groups, particularly between academia and industry.
In this publication, an excerpt of projects funded in the ¿Cell Factory¿ sub-area ¿Improving the diagnostic and therapeutic arsenal for healthcare¿ is presented, focussing on those projects, which aim at or include clinical studies, thus being at the forefront of medical applications derived from biotechnological breakthroughs.
The present publication has been prepared with a dual objective in mind. Firstly, it seeks to inform, in a comprehensible way, policy-makers and the society at the large on the opportunities biotechnology offers to medicine and secondly, it aims at promoting ¿technological Platforms¿ involving all stakeholders active and concerned in particular biotechnology fields and to stimulate ¿translational¿ research.

Additional information

Authors: RAINER B, European Commission, DG Research, Brussels (BE)
Bibliographic Reference: EUR 20802 EN (2003), 209 pp. Free of charge
Availability: EUR-OP reference: KI-NA-20-802-EN-C Available from: Documentation Service of DG Research Fax: +32-2-2958220 E-mail:
ISBN: ISBN: 92-894-5957-3
Record Number: 200417387 / Last updated on: 2004-02-02
Original language: en
Available languages: en